JP2022540432A - カンナビノイド誘導体 - Google Patents

カンナビノイド誘導体 Download PDF

Info

Publication number
JP2022540432A
JP2022540432A JP2022500795A JP2022500795A JP2022540432A JP 2022540432 A JP2022540432 A JP 2022540432A JP 2022500795 A JP2022500795 A JP 2022500795A JP 2022500795 A JP2022500795 A JP 2022500795A JP 2022540432 A JP2022540432 A JP 2022540432A
Authority
JP
Japan
Prior art keywords
alkyl
compound
pentyl
benzo
dioxino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2022500795A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022540432A5 (https=
JPWO2021007660A5 (https=
Inventor
アラン オメーラ，ジェフリー
フィ ト，クアン
トーマス ガニング，パトリック
Original Assignee
キャノピー グロウス コーポレイション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by キャノピー グロウス コーポレイション filed Critical キャノピー グロウス コーポレイション
Publication of JP2022540432A publication Critical patent/JP2022540432A/ja
Publication of JP2022540432A5 publication Critical patent/JP2022540432A5/ja
Publication of JPWO2021007660A5 publication Critical patent/JPWO2021007660A5/ja
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
JP2022500795A 2019-07-12 2020-07-10 カンナビノイド誘導体 Ceased JP2022540432A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962873686P 2019-07-12 2019-07-12
US62/873,686 2019-07-12
PCT/CA2020/050966 WO2021007660A1 (en) 2019-07-12 2020-07-10 Cannabinoid derivatives

Publications (3)

Publication Number Publication Date
JP2022540432A true JP2022540432A (ja) 2022-09-15
JP2022540432A5 JP2022540432A5 (https=) 2023-07-13
JPWO2021007660A5 JPWO2021007660A5 (https=) 2023-07-13

Family

ID=74209617

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022500795A Ceased JP2022540432A (ja) 2019-07-12 2020-07-10 カンナビノイド誘導体

Country Status (5)

Country Link
US (1) US20220259221A1 (https=)
EP (1) EP3997095B1 (https=)
JP (1) JP2022540432A (https=)
ES (1) ES3014632T3 (https=)
WO (1) WO2021007660A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3997098A4 (en) 2019-07-12 2023-10-11 Canopy Growth Corporation CANNABINOIDS DERIVATIVES
WO2021007663A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
JP2022540586A (ja) 2019-07-12 2022-09-16 キャノピー グロウス コーポレイション カンナビノイド誘導体
WO2021062559A1 (en) 2019-10-02 2021-04-08 Canopy Growth Corporation Cannabinoid derivatives
EP4065554A4 (en) 2019-11-26 2024-01-10 Canopy Growth Corporation CANNABIGEROL DERIVATIVES AND THEIR USE AS CANNABINOID RECEPTOR MODULATORS
KR20240096817A (ko) 2020-05-19 2024-06-26 사이빈 아이알엘 리미티드 중수소화된 트립타민 유도체 및 사용 방법
EP4222260A4 (en) * 2020-10-02 2025-01-15 Bessor Pharma, LLC PROCESS FOR THE PRODUCTION OF CANNABINOL, CANNABINOLIC ACID, CANNABIVARIN, CANNABIVARIN ACID AND RELATED CANNABINOIDS
EP4471038A1 (en) 2023-05-30 2024-12-04 Tresco Holding GmbH Process for the synthesis of tetrahydrocannabinolic acid dimethylsiloxane, and tetrahydrocannabinolic acid dimethylsiloxane

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050009903A1 (en) * 2003-06-10 2005-01-13 Martin Billy R. CB2-selective cannabinoid analogues
WO2014039042A1 (en) * 2012-09-06 2014-03-13 Northeastern University Novel cannabinergic compounds and uses thereof
WO2014134127A1 (en) * 2013-02-26 2014-09-04 Northeastern University Cannabinergic nitrate esters and related analogs
JP2021535201A (ja) * 2018-08-20 2021-12-16 ベッソール ファルマ、エルエルシー カンナビノイドの作成のためのプロセス

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070179135A1 (en) * 2006-01-05 2007-08-02 Travis Craig R Cannabinoid derivatives
BR0009200A (pt) * 1999-03-22 2001-12-26 Immugen Pharmaceuticals Inc Compostos e composições para o tratamento dedoenças associada com disfunção imune
WO2019234728A1 (en) * 2018-06-04 2019-12-12 Al&Am Pharmachem Ltd. Cannabinolic acid derivatives and uses thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050009903A1 (en) * 2003-06-10 2005-01-13 Martin Billy R. CB2-selective cannabinoid analogues
WO2014039042A1 (en) * 2012-09-06 2014-03-13 Northeastern University Novel cannabinergic compounds and uses thereof
WO2014134127A1 (en) * 2013-02-26 2014-09-04 Northeastern University Cannabinergic nitrate esters and related analogs
JP2021535201A (ja) * 2018-08-20 2021-12-16 ベッソール ファルマ、エルエルシー カンナビノイドの作成のためのプロセス

Also Published As

Publication number Publication date
EP3997095A1 (en) 2022-05-18
EP3997095A4 (en) 2022-12-28
EP3997095C0 (en) 2025-02-12
ES3014632T3 (en) 2025-04-23
WO2021007660A1 (en) 2021-01-21
US20220259221A1 (en) 2022-08-18
EP3997095B1 (en) 2025-02-12

Similar Documents

Publication Publication Date Title
JP2022540432A (ja) カンナビノイド誘導体
JP2022539400A (ja) カンナビノイド誘導体
JP7684945B2 (ja) カンナビノイド誘導体
JP2022539401A (ja) カンナビノイド誘導体
JP2022551067A (ja) カンナビノイド誘導体
JP2022540433A (ja) カンナビノイド誘導体
US12195429B2 (en) Cannabinoid derivatives
JP2023505517A (ja) カンナビノイド誘導体
JP2023505513A (ja) カンナビノイド誘導体
JP2022551066A (ja) カンナビノイド誘導体
JP2023503331A (ja) カンナビノイド誘導体
US12084407B2 (en) Cannabigerol derivatives and use thereof as cannabinoid receptor modulators
JP2022540585A (ja) カンナビノイド誘導体
JP2023503330A (ja) カンナビノイド誘導体

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230705

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230705

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20240312

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240402

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240702

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240917

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20241028

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250314

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250603

A045 Written measure of dismissal of application [lapsed due to lack of payment]

Free format text: JAPANESE INTERMEDIATE CODE: A045

Effective date: 20251028